Health outcome or symptom | Exposure to damp indoor environments | Presence of mold/other agents in damp indoor environments |
---|---|---|
Upper respiratory tract symptoms1 | Sufficient evidence of an association7 | |
Cough2 | Sufficient evidence of an association | |
Wheeze2 | Sufficient evidence of an association | |
Asthma symptoms in sensitized persons with asthma | Sufficient evidence of an association | |
Hypersensitivity pneumonitis3 in susceptible persons | Studied in relation to specific agents | Sufficient evidence of an association |
Shortness of breath (dyspnea)2 | Limited or suggestive evidence8 | Inadequate or insufficient evidence9 |
Respiratory illness in otherwise healthy children | Limited or suggestive evidence | |
Respiratory illness in otherwise healthy adults |
Inadequate or insufficient evidence | |
Acute idiopathic pulmonary hemorrhage in infants | Inadequate or insufficient evidence | |
Fungal sinusitis4 | No specific studies associated the condition with damp or moldy indoor spaces | |
Severe respiratory infections in people whose immune system is severely immunocompromised5 | Not applicable10 | Sufficient evidence of an association |
Fungus-related illnesses in people whose immune system is severely immunocompromised5 and who have chronic obstructive pulmonary disease (COPD) | Not applicable10 | Sufficient evidence of an association |
Colonization and potential lung infection in people with some chronic pulmonary disorders6 | Not applicable10 | Sufficient evidence of an association |
Institute of Medicine’s "Damp Indoor Spaces and Health" (http://www.nap.edu/books/0309091934/html/). [external link]